Del Mar, CA, United States of America

Peter Edward Vaillancourt

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 2003-2018

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Edward Vaillancourt

Introduction

Peter Edward Vaillancourt is a remarkable inventor based in Del Mar, California. With an impressive portfolio of 12 patents, he has made significant contributions to the fields of medicine and biotechnology. His work primarily focuses on developing innovative solutions for various health-related challenges.

Latest Patents

Two of his latest patents exemplify his groundbreaking work in addressing critical medical issues. The first patent, titled "VEGFA/Ang2 Compounds," relates to compounds that effectively bind to human vascular endothelial growth factor A (VEGFA) and human angiopoietin-2 (Ang2). These compounds are poised to be instrumental in treating angiogenic eye diseases, including diabetic retinopathy and other proliferative retinopathies. Additionally, they hold promise in combatting solid tumors driven by VEGFA and Ang2, including various types of cancer such as gastric, lung, hepatocellular carcinoma, ovarian, colorectal, and breast cancers.

The second noteworthy patent is focused on "Anti-c-Met Antibodies." This invention encompasses antibodies and antigen-binding fragments that specifically bind to the extracellular domain of human c-Met. These c-Met antibodies, along with their respective compositions and detection methods, are designed to identify patients with tumors that express or overexpress human Met, thereby potentially enhancing their treatment response with anti-c-Met therapeutics.

Career Highlights

Peter's career has been marked by his association with prominent companies in the biotech and pharmaceutical industries, including Eli Lilly and Company and Stratagene California. His experiences in these organizations have contributed to his deep expertise and innovative outlook on biotechnology.

Collaborations

Throughout his career, Peter has collaborated with several notable individuals, including Julian Davies and David Matthew Marquis. These partnerships have facilitated the development of pioneering technologies and therapeutic solutions that continue to impact the medical field.

Conclusion

Peter Edward Vaillancourt's dedication to innovation in healthcare is evident through his extensive patent portfolio and collaborative efforts. His inventions have the potential to transform the landscape of treatment for various diseases, reaffirming his status as a leading figure in the field of biomedicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…